𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly

✍ Scribed by Moises Mercado; Fatima Borges; Hakim Bouterfa; Tien-Chun Chang; Alberto Chervin; Andrew J. Farrall; Attila Patocs; Stephan Petersenn; Jan Podoba; Mitra Safari; Joanna Wardlaw; on behalf of the SMS995B2401 Study Group

Book ID
108703715
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
332 KB
Volume
66
Category
Article
ISSN
0300-0664

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre